190 related articles for article (PubMed ID: 21976226)
1. Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15.
Ayalew S; Shrestha B; Montelongo M; Wilson AE; Confer AW
Clin Vaccine Immunol; 2011 Dec; 18(12):2067-74. PubMed ID: 21976226
[TBL] [Abstract][Full Text] [Related]
2. Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein.
Confer AW; Ayalew S; Montelongo M; Step DL; Wray JH; Hansen RD; Panciera RJ
Vaccine; 2009 Mar; 27(11):1771-6. PubMed ID: 18834912
[TBL] [Abstract][Full Text] [Related]
3. Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B.
Ayalew S; Step DL; Montelongo M; Confer AW
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):295-302. PubMed ID: 19581005
[TBL] [Abstract][Full Text] [Related]
4. Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF.
Ayalew S; Shrestha B; Montelongo M; Wilson AE; Confer AW
Vaccine; 2011 Nov; 29(47):8712-8. PubMed ID: 21875637
[TBL] [Abstract][Full Text] [Related]
5. A chimeric protein comprising the immunogenic domains of Mannheimia haemolytica leukotoxin and outer membrane protein PlpE induces antibodies against leukotoxin and PlpE.
Batra SA; Shanthalingam S; Donofrio G; Srikumaran S
Vet Immunol Immunopathol; 2016 Jul; 175():36-41. PubMed ID: 27269790
[TBL] [Abstract][Full Text] [Related]
6. Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin.
Ayalew S; Confer AW; Payton ME; Garrels KD; Shrestha B; Ingram KR; Montelongo MA; Taylor JD
Vaccine; 2008 Sep; 26(38):4955-61. PubMed ID: 18675308
[TBL] [Abstract][Full Text] [Related]
7. Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE.
Ayalew S; Confer AW; Blackwood ER
Infect Immun; 2004 Dec; 72(12):7265-74. PubMed ID: 15557652
[TBL] [Abstract][Full Text] [Related]
8. Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1.
Pandher K; Confer AW; Murphy GL
Infect Immun; 1998 Dec; 66(12):5613-9. PubMed ID: 9826333
[TBL] [Abstract][Full Text] [Related]
9. Cloning and Expression of Mannheimia haemolytica PlpE Gene in Escherichia coli and its Immunogenicity Assessment.
Yektaseresht A; Sabet Sarvestani F; Dordani M; Hosseini A
Arch Razi Inst; 2019 Jun; 74(2):111-118. PubMed ID: 31232560
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination of young Holstein calves with Mannheimia haemolytica chimeric protein PlpE-LKT (SAC89) and cholera toxin.
Confer AW; Ayalew S; Step DL; Trojan B; Montelongo M
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):232-6. PubMed ID: 19477022
[No Abstract] [Full Text] [Related]
11. Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.
Roier S; Fenninger JC; Leitner DR; Rechberger GN; Reidl J; Schild S
Int J Med Microbiol; 2013 Jul; 303(5):247-56. PubMed ID: 23731905
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge.
Confer AW; Ayalew S; Panciera RJ; Montelongo M; Wray JH
Vaccine; 2006 Mar; 24(13):2248-55. PubMed ID: 16430995
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis and immunogenicity of Mannheimia haemolytica vesicles.
Ayalew S; Confer AW; Shrestha B; Wilson AE; Montelongo M
Clin Vaccine Immunol; 2013 Feb; 20(2):191-6. PubMed ID: 23239798
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine.
Confer AW; Ayalew S; Panciera RJ; Montelongo M; Whitworth LC; Hammer JD
Vaccine; 2003 Jun; 21(21-22):2821-9. PubMed ID: 12798623
[TBL] [Abstract][Full Text] [Related]
15. Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine.
Batra SA; Shanthalingam S; Donofrio G; Haldorson GJ; Chowdhury S; White SN; Srikumaran S
Vaccine; 2017 Mar; 35(12):1630-1636. PubMed ID: 28228321
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1.
Confer AW; McCraw RD; Durham JA; Morton RJ; Panciera RJ
Vet Immunol Immunopathol; 1995 Jul; 47(1-2):101-10. PubMed ID: 8533287
[TBL] [Abstract][Full Text] [Related]
17. Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2, and 6.
Ayalew S; Blackwood ER; Confer AW
Vet Microbiol; 2006 May; 114(3-4):260-8. PubMed ID: 16386856
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of an outer membrane protein of Pasteurella haemolytica A2, A7 or A9-enriched vaccine against intratracheal challenge exposure in sheep.
Sabri MY; Zamri-Saad M; Mutalib AR; Israf DA; Muniandy N
Vet Microbiol; 2000 Apr; 73(1):13-23. PubMed ID: 10731614
[TBL] [Abstract][Full Text] [Related]
19. LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge.
Guzmán-Brambila C; Quintero-Fabián S; González-Castillo C; de Obeso-Fernández del Valle Á; Flores-Samaniego B; de la Mora G; Rojas-Mayorquín AE; Ortuño-Sahagún D
Res Vet Sci; 2012 Dec; 93(3):1293-300. PubMed ID: 22840333
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a Pasteurella haemolytica A1 mutant deficient in production of three membrane lipoproteins.
Murphy GL; Whitworth LC; Confer AW; Gaskins JD; Pandher K; Dabo SM
Am J Vet Res; 1998 Oct; 59(10):1275-80. PubMed ID: 9781461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
